XinWu
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Single Arm Phase I Trail of Autologous Tumor Infiltrating Lymphocyte Injection (GT202) in the Treatment of Metastatic or Recurrent Gynecological Tumors (NCT05238818) | XinWu | 2022-03-01 |
Track XinWu automatically
Every clearance here is in the API, with alerts when new ones post.